Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026)

Repligen (RGEN) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $2.9 billion in Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 2.76% year-over-year to $2.9 billion in Q1 2026; TTM through Mar 2026 was $11.7 billion, a 2.88% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 4.24% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $2.9 billion, down from $2.9 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for RGEN reached as high as $2.9 billion in Q4 2025 and fell as low as $2.4 billion in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $2.7 billion across 5 years, with a median of $2.8 billion in 2024.
• Across the five-year window, Liabilities and Shareholders Equity gained 23.69% in 2022 and retreated 0.05% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $2.5 billion in 2022, then grew by 11.83% to $2.8 billion in 2023, then dropped by 0.05% to $2.8 billion in 2024, then grew by 4.24% to $2.9 billion in 2025, then declined by 0.64% to $2.9 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $2.9 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.